Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alex Bajamonde"'
Autor:
Grazyna Leiberman, Robert L. Cohen, Bryan McCune, Noel Dybdal, Alex Bajamonde, Robert D. Mass, Steven M. Anderson, Corsee Sanders, Michael F. Press
Publikováno v:
Breast Cancer Research and Treatment. 93:3-11
Purpose. To evaluate the concordance between HER2 gene amplification, determined by fluorescence in situ hybridization (FISH), and HER2 protein overexpression assessed by an immunohistochemical (IHC) assay. The IHC protocol used was a research assay,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6002acaaf187b2d5afbf1d285c35615e
https://doi.org/10.1007/s10549-004-6275-8
https://doi.org/10.1007/s10549-004-6275-8
Autor:
Martin E. Gleave, Mostafa Elhilali, Yves Fradet, Ian Davis, Peter Venner, Fred Saad, Laurence H. Klotz, Malcolm J. Moore, Virginia Paton, Alex Bajamonde, David Bell, Scott Ernst, Ernest Ramsey, Joe Chin, Alvaro Morales, Heidi Martins, Coree Sanders
Publikováno v:
New England Journal of Medicine. 338:1265-1271
Background Most trials of immunomodulators in metastatic renal-cell carcinoma have been uncontrolled and subject to selection bias. The objective of this blinded, placebo-controlled study was to compare overall response rates, time to disease progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b18eb9c33d3d3cb1487a292ca80adbd
https://doi.org/10.1056/nejm199804303381804
https://doi.org/10.1056/nejm199804303381804
Publikováno v:
Data Monitoring in Clinical Trials ISBN: 9780387203300
Genentech’s phase III study of colorectal cancer aimed to show that administration of bevacizumab, its recombinant human anti-vascular endothelial growth factor antibody, to patients with metastatic colorectal cancer would reduce mortality. The fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb59bb52b90c65dcdeef3281e206a1c1
https://doi.org/10.1007/0-387-30107-0_35
https://doi.org/10.1007/0-387-30107-0_35
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(8)
Understanding Gene Alterations in Human Breast Cancer Gene alterations play an important role in the origin and pathogenesis of human breast cancer. Three broad categories of gene changes that appear to contribute to tumor progression include tumor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039b3f75a56026c68e41b838a5022694
https://pubmed.ncbi.nlm.nih.gov/15755966
https://pubmed.ncbi.nlm.nih.gov/15755966
Autor:
Timothy D. Henry, Amy Chen Rundle, James T. Willerson, Frank J. Giordano, Brian H. Annex, Daniel S. Berman, Edward R. McCluskey, John J. Lopez, George R. McKendall, Alex Bajamonde, J. T. Fine, Prediman K. Shah, C. Michael Gibson, Raymond L. Benza, Michael Azrin
Publikováno v:
Circulation. 107(10)
Background— Recombinant human vascular endothelial growth factor protein (rhVEGF) stimulates angiogenesis in animal models and was well tolerated in Phase I clinical trials. VIVA (Vascular endothelial growth factor in Ischemia for Vascular Angiogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668faac8c4bf6808834eea633b109d6b
https://pubmed.ncbi.nlm.nih.gov/12642354
https://pubmed.ncbi.nlm.nih.gov/12642354
Autor:
Wolfgang Eiermann, Steven Shak, José Baselga, Hank Fuchs, Mark D. Pegram, Virginia E. Paton, Thomas Fleming, Janet M. Wolter, Dennis J. Slamon, Alex Bajamonde, Larry Norton, Brian Leyland-Jones
Publikováno v:
The New England journal of medicine. 344(11)
The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30 percent of breast cancers, increasing the aggressiveness of the tumor.We evaluated the efficacy and safety of trastuzumab, a recombinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0851e52b8f5d03bd56f7a1c125b8752
https://pubmed.ncbi.nlm.nih.gov/11575297
https://pubmed.ncbi.nlm.nih.gov/11575297